Your Input: | |||||
GSX2 | GS homeobox 2. (279 aa) | ||||
NKX6-2 | NK6 homeobox 2. (278 aa) | ||||
MAG | Myelin associated glycoprotein. (633 aa) | ||||
SERPINE2 | Serpin family E member 2; Belongs to the serpin family. (403 aa) | ||||
LOC102356309 | Uncharacterized protein. (314 aa) | ||||
H3A2T1_LATCH | Uncharacterized protein. (573 aa) | ||||
LOC102356030 | Uncharacterized protein. (313 aa) | ||||
H2ZZI1_LATCH | RING-type domain-containing protein. (424 aa) | ||||
PTPRZ1 | Protein tyrosine phosphatase receptor type Z1. (2273 aa) | ||||
CLCF1 | Cardiotrophin like cytokine factor 1. (235 aa) | ||||
ASPA | Aspartoacylase. (249 aa) | ||||
TNFRSF1B | TNF receptor superfamily member 1B. (465 aa) | ||||
NKX6-1 | NK6 homeobox 1. (316 aa) | ||||
LOC102350310 | GBP domain-containing protein. (339 aa) | ||||
TP73 | Cellular tumor antigen p53; Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression; Belongs to the p53 family. (636 aa) | ||||
MDK | Midkine. (141 aa) | ||||
TGFB1 | Transforming growth factor beta; Belongs to the TGF-beta family. (401 aa) | ||||
MTOR | Mechanistic target of rapamycin kinase; Belongs to the PI3/PI4-kinase family. (1009 aa) | ||||
H3B938_LATCH | Teneurin N-terminal domain-containing protein. (181 aa) | ||||
H3B8U3_LATCH | Serine/threonine-protein kinase TOR. (1418 aa) | ||||
H3B780_LATCH | Uncharacterized protein. (370 aa) | ||||
H3B181_LATCH | Teneurin transmembrane protein 4. (1031 aa) | ||||
PTN | Pleiotrophin. (167 aa) | ||||
H3B6N2_LATCH | Teneurin N-terminal domain-containing protein. (214 aa) | ||||
IL6ST | Interleukin 6 signal transducer. (922 aa) |